These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2507491)

  • 1. Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.
    Kodama K; Morozumi M; Saitoh K; Kuninaka A; Yoshino H; Saneyoshi M
    Jpn J Cancer Res; 1989 Jul; 80(7):679-85. PubMed ID: 2507491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
    Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
    Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors.
    Higashigawa M; Cao DC; Matsui K; Yamada S; Kakitou H; Kagawa Y; Inamochi H; Ido M; Sakurai M
    Cancer Chemother Pharmacol; 1994; 33(4):281-5. PubMed ID: 8281619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
    Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
    Fukuoka M; Miyazaki T; Yoshida Y; Hattori M; Niitani H; Nakamura T; Hirota Y; Ohta K; Tanaka M; Suzuoki Y
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
    Schleyer E; Braess J; Ramsauer B; Unterhalt M; Kaufmann C; Wilde S; Schüssler M; Hiddemann W
    Leukemia; 1995 Jun; 9(6):1085-90. PubMed ID: 7596174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids and selected lipophilic alcohols.
    Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
    J Med Chem; 1985 Feb; 28(2):171-7. PubMed ID: 3968680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
    Braess J; Freund M; Hanauske A; Heil G; Kaufmann C; Kern W; Schüssler M; Hiddemann W; Schleyer E
    Leukemia; 1998 Oct; 12(10):1618-26. PubMed ID: 9766508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
    Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate.
    Ohno R; Tatsumi N; Hirano M; Imai K; Mizoguchi H; Nakamura T; Kosaka M; Takatsuki K; Yamaya T; Toyama K
    Oncology; 1991; 48(6):451-5. PubMed ID: 1749580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
    Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
    Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
    Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of YNK 01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) in patients with polycythemia vera].
    Naito K; Kitaori K; Morishima Y
    Gan To Kagaku Ryoho; 1993 May; 20(7):973-6. PubMed ID: 8489306
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of myelodysplastic syndrome with 1-beta-D-arabinofuranosylcytosine 5'-stearylphosphate.
    Ueda T; Imamura S; Kawai Y; Wano Y; Kamiya K; Tsutani H; Nakamura T
    Leuk Res; 1990; 14(11-12):1067-8. PubMed ID: 2280605
    [No Abstract]   [Full Text] [Related]  

  • 20. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
    J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.